The city of Sugar Land is helping support the expansion of Hope Biosciences, a Sugar Land-based biopharmaceutical company specializing in adult stem cell-based therapeutics, the city announced in a ...
U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat ...
Bengaluru: AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to ...
Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership ...
There was no money for me to continue raising on a sub small scale plant-based meat company in 2025. That path is over." ...
Total preliminary 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively, representing 65% and 66% annual growth, respectively ...
Hospice Mississauga is proud to announce that construction has officially commenced on the city's first-ever dedicated ...
Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS in August 2025, the first-and-only FDA-approved treatment for adults with RRP ...
The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts demonstrate that modest (~10%) NfL reductions are signi ...
Continued strong growth of ZORYVE® (roflumilast) in 2026 with full-year net product sales guidance of $455-$470 millionAdvancement of ZORYVE indication-expansion strategy beginning with ongoing Phase ...
Detailed price information for Aeon Biopharma Inc (AEON-A) from The Globe and Mail including charting and trades.
Spatial Design, Breaking the 2D Paradigm,' a new book by Dominique Wu, puts forth design principles for spatial computing, XR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback